Evidence map›Paper›PMID 28404638›Full record

ArticleJournal of lipid research2017

Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids.

Diego Scerbo, Ni-Huiping Son, Alaa Sirwi, Lixia Zeng, Kelli M Sas, Vincenza Cifarelli, Gabriele Schoiswohl, Lesley-Ann Huggins, Namrata Gumaste, Yunying Hu and 6 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Chronic exposure to low levels of glyphosate and metals induces kidney dysfunction.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Targeting de novo lipogenesis to mitigate kidney disease.The Journal of clinical investigation · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Diego ScerboDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY.
Ni-Huiping SonDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY.
Alaa SirwiDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Lixia ZengDivision of Nephrology, University of Michigan, Ann Arbor, MI.
Kelli M SasDivision of Nephrology, University of Michigan, Ann Arbor, MI.
Vincenza CifarelliDepartment of Medicine, Washington University, St. Louis, MO.
Gabriele SchoiswohlDivision of Endocrinology, University of Pittsburgh, Pittsburgh, PA.
Lesley-Ann HugginsDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY.
Namrata GumasteDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY.
Yunying HuDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY.
Subramaniam PennathurDivision of Nephrology, University of Michigan, Ann Arbor, MI.
Nada A AbumradDepartment of Medicine, Washington University, St. Louis, MO.
Erin E KershawDivision of Endocrinology, University of Pittsburgh, Pittsburgh, PA.
M Mahmood HussainDepartment of Cell Biology, State University of New York Downstate Medical Center, Brooklyn, NY.
Katalin SusztakDivision of Renal Electrolyte and Hypertension, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Ira J GoldbergDivision of Endocrinology, Diabetes, and Metabolism, New York University School of Medicine, New York, NY ira.goldberg@nyumc.org.
New York University · USUniversity of Michigan–Ann Arbor · USUniversity of Pittsburgh · USWashington University in St. Louis · USState University of New York · USSUNY Downstate Health Sciences University · USUniversity of Pennsylvania · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Integrated Systems Biology Approach to Diabetic Microvascular ComplicationsR24DK082841 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABCOUWER, STEVEN F, BROSIUS, FRANK C · 2008 to 2020
$13.1M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Statistics and Bioinformatics Core - WangU24DK097153 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2012 to 2017
$10.1M
Role of the Notch Pathway in Kidney InjuryR01DK076077 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2007 to 2026
$8.0M
CD36 AND INTESTINAL FAT ABSORPTIONR01DK060022 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 2001 to 2021
$7.7M
Epigenetics of Chronic Kidney DiseaseR01DK087635 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2009 to 2026
$7.0M
Pathways of Tissue Lipid UptakeR01HL045095 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABUMRAD, NADA A., GOLDBERG, IRA J · 1991 to 2024
$6.9M
Mechanisms of Fatty Acid Uptake By Cardiac MuscleR01HL073029 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GOLDBERG, IRA J · 2003 to 2021
$6.8M
NCATS NIH HHS UL1 TR000433NCI NIH HHS P30 CA016087NHLBI NIH HHS R01 HL045095NHLBI NIH HHS R01 HL073029NHLBI NIH HHS R37 HL045095NIDDK NIH HHS DP3 DK094292NIDDK NIH HHS DP3 DK108220NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK081943NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK033301NIDDK NIH HHS R01 DK060022NIDDK NIH HHS R01 DK076077NIDDK NIH HHS R01 DK087635NIDDK NIH HHS R01 DK090166NIDDK NIH HHS R01 DK105821NIDDK NIH HHS R24 DK082841NIDDK NIH HHS R56 DK046900NIDDK NIH HHS R56 DK090166NIDDK NIH HHS U24 DK097153
6 · The paper itself

Abstract

Lipid accumulation is a pathological feature of every type of kidney injury. Despite this striking histological feature, physiological accumulation of lipids in the kidney is poorly understood. We studied whether the accumulation of lipids in the fasted kidney are derived from lipoproteins or NEFAs. With overnight fasting, kidneys accumulated triglyceride, but had reduced levels of ceramide and glycosphingolipid species. Fasting led to a nearly 5-fold increase in kidney uptake of plasma [

Indexed as

AnimalsFastingFatty Acids, NonesterifiedFemaleKidneyMaleMiceMice, Inbred C57BLOxidation-ReductionTriglyceridesFatty Acids, NonesterifiedTriglyceridescluster of differentiation 36kidney metabolismlipoprotein lipase

Identifiers

PMID28404638
PMCPMC5454509
OpenAlexW2606214113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.